d-band-modulated bimetallic PtCo nanozymes with molecular imprinting for depression diagnostics | Synapse
March 3, 2026
d-band-modulated bimetallic PtCo nanozymes with molecular imprinting for depression diagnostics
Key Points
Bimetallic PtCo nanozymes enhance diagnostic accuracy for depression, indicating significant potential in mental health assessment.
D-band modulation of these nanozymes results in improved interaction with biomarkers, showing a 30% increase in detection sensitivity.
Using molecular imprinting, a specific technique for improved detection of depression-related markers, was employed to fine-tune the nanozymes' capabilities.
Findings highlight the promise of nanozymes in diagnostics, underscoring the need for further studies to explore clinical applicability.